3-Iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-ol, 98%, 250mg

Methyl 2,2,3,3-tetrafluoropropyl ether, 97.0%, 5g

Zirconium(IV) oxide, nano, hydrophobic, ROTI®nanoMETIC, 3 nm, hydrophobic, 1 g, glass packaging

(2S,4R)-1-(tert-Butoxycarbonyl)-4-hydroxy-2-(hydroxymethyl)pyrrolidine>96.0%(GC)1g

4-Chlorothioanisole>98.0%(GC)10g

Methyl 2,3,4,6-Tetra-O-acetyl-1-thio-alpha-D-mannopyranoside (contains ca. 5% beta-isomer)>95.0%(HPLC)5g

(9,9-Diphenyl-9H-fluoren-4-yl)boronic acid, 97.0%, 10g

4'-Fluorobiphenyl-3-ylamine, 95.0%, 5g

4-Ethoxy-6-(3-methyl-piperazin-1-yl)-2-methylsulfanyl-pyrimidine hydrochloride, 95.0%, 100mg

N-(4-bromophenyl)cinnamamide, 95.0%, 500mg

Specimen slide boxes ROTILABO® Hinged lid, Number of spaces required, 50, white 1 piece

N-(8-Nitro-3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)acetamide, 95.0%, 100mg

7-(2-Methoxyethoxy)-4-oxo-1,4-dihydroquinazolin-6-yl acetate, 98%, 1g